Related Experiment Video
Updated: May 17, 2026
Assessment of Sarcoplasmic Reticulum Calcium Reserve and Intracellular Diastolic Calcium Removal in Isolated Ventricular Cardiomyocytes
Published on: September 18, 2017
Setting Snail2's pace during EMT
Haritha Mathsyaraja1, Michael C Ostrowski
1Molecular, Cellular and Developmental Biology Program, Ohio State University, and the OSU Comprehensive Cancer Center, Columbus, Ohio, USA.
Abstract:
Epithelial to mesenchymal transition (EMT) is a fundamental process in both development and cancer progression. The transcription factor Elf5 is now reported as an upstream regulator of the key EMT inducer Snail2, and is shown to regulate the earliest known rewiring events required for tumour cell invasiveness and metastasis.
Insights
The transcription factor Elf5 regulates Snail2, a key inducer of epithelial to mesenchymal transition (EMT). This finding reveals Elf5
Area of Science:
- Molecular Biology
- Cancer Research
- Developmental Biology
Background:
- Epithelial to mesenchymal transition (EMT) is a critical biological process.
- EMT plays a significant role in embryonic development and cancer metastasis.
- Understanding EMT regulators is crucial for cancer therapy development.
Purpose of the Study:
- To investigate the role of transcription factor Elf5 in regulating EMT.
- To identify Elf5 as an upstream regulator of Snail2, a key EMT inducer.
- To elucidate Elf5's function in early cellular changes driving tumor invasiveness.
Main Methods:
- Molecular and cellular biology techniques were employed.
- Analysis of transcription factor interactions and gene regulation.
- Investigation of pathways involved in tumor cell metastasis.
Main Results:
- Elf5 was identified as a direct upstream regulator of Snail2.
- Elf5 influences the earliest cellular rewiring events in EMT.
- These Elf5-mediated changes are critical for tumor cell invasiveness.
Conclusions:
- Elf5 is a key regulator of EMT, acting upstream of Snail2.
- Elf5's role in initiating EMT contributes to cancer metastasis.
- Targeting Elf5 may offer a novel therapeutic strategy for invasive cancers.
